What are the Approved Immunotherapies for Gynecologic Cancers?
In gynecologic oncology, several immunotherapies have gained approval. For instance, Pembrolizumab is approved for certain cases of cervical cancer, especially those expressing PD-L1. For ovarian cancer, combinations of bevacizumab with immune checkpoint inhibitors are under investigation. Additionally, nivolumab and other PD-1 inhibitors are being explored in clinical trials for various gynecologic malignancies.
